ATEYX
Price
$142.18
Change
+$11.66 (+8.93%)
Updated
Apr 9 closing price
Net Assets
1.35B
NPFCX
Price
$54.57
Change
+$3.98 (+7.87%)
Updated
Apr 9 closing price
Net Assets
122.54B
Ad is loading...

ATEYX vs NPFCX

Header iconATEYX vs NPFCX Comparison
Open Charts ATEYX vs NPFCXBanner chart's image
AB Sustainable Global Thematic Advisor
Price$142.18
Change+$11.66 (+8.93%)
VolumeN/A
Net Assets1.35B
American Funds New Perspective C
Price$54.57
Change+$3.98 (+7.87%)
VolumeN/A
Net Assets122.54B
ATEYX vs NPFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ATEYX vs. NPFCX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATEYX is a Buy and NPFCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
NPFCX has more cash in the bank: 123B vs. ATEYX (1.35B). ATEYX (0.00) and NPFCX (0.00) have matching dividends . ATEYX was incepted earlier than NPFCX: ATEYX (29 years) vs NPFCX (24 years). NPFCX (1.48) is less costly to investors than ATEYX (0.78). ATEYX is a more actively managed with annual turnover of: 31.00 vs. NPFCX (24.00). ATEYX has a lower initial minimum investment than NPFCX: ATEYX (0) vs NPFCX (250). NPFCX annual gain was more profitable for investors over the last year : -10.63 vs. ATEYX (-20.79). NPFCX return over 5 years is better than : 30.30 vs. ATEYX (12.33).
ATEYXNPFCXATEYX / NPFCX
Total Expense Ratio0.771.4852%
Annual Report Gross Expense Ratio0.781.4853%
Fund Existence29 years24 years-
Gain YTD-16.781-12.625133%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.35B123B1%
Annual Yield % from dividends0.000.00-
Returns for 1 year-20.79-10.63196%
Returns for 3 years-18.33-7.88232%
Returns for 5 years12.3330.3041%
Returns for 10 years41.1634.66119%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GLDD8.810.77
+9.64%
Great Lakes Dredge & Dock Corp
GMAB18.830.85
+4.73%
Genmab A/S ADS
INTR5.260.22
+4.46%
Inter & Co
ALDX1.930.01
+0.78%
Aldeyra Therapeutics
SONN1.25N/A
+0.34%
Sonnet BioTherapeutics Holdings Inc